(Updates shares in paragraph 3, explanation of share drop in paragraph 4) By Maggie Fick LONDON, May 2 (Reuters) – Novo Nordisk raised its 2024 outlook on Thursday and delivered better-than-expected first-quarter profits as the Danish drugmaker races to boost output of its Wegovy weight-loss drug and fend off competition from rival Eli Lilly. Novo […]